← Open Payments lookup

LISA DOLLMAN: Open Payments

NPI 1548912678 · ROSEDALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$564 in 18 payments from 10 companies in 2025. Trend: 2023 $43 · 2024 $198 · 2025 $564

Food & beverage: $564
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$162
Biogen, Inc.1$107
ABBVIE INC.4$83
Collegium Pharmaceutical, Inc.2$55
Sage Therapeutics, LLC1$38
Neurocrine BioSciences, Inc.1$36
Janssen Pharmaceuticals, Inc1$29
E.R. Squibb & Sons, L.L.C.1$21
Tris Pharma Inc1$19
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: HETLIOZ, ZURZUVAE, VRAYLAR, Jornay PM, INGREZZA, SPRAVATO, COBENFY, Dyanavel XR.

Industry payments across MD — which companies pay providers there.